TY - JOUR
T1 - Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus
AU - Hagadorn, James I.
AU - Brownell, Elizabeth A.
AU - Trzaski, Jennifer M.
AU - Johnson, Kendall R.
AU - Lainwala, Shabnam
AU - Campbell, Brendan T.
AU - Herbst, Katherine W.
N1 - Publisher Copyright:
Copyright © 2016 International Pediatric Research Foundation, Inc.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Background:We examined recent trends and interhospital variation in use of indomethacin, ibuprofen, and surgical ligation for patent ductus arteriosus (PDA) in very-low-birth-weight (VLBW) infants.Methods:Included in this retrospective study of the Pediatric Hospital Information System database were 13,853 VLBW infants from 19 US children's hospitals, admitted at age < 3 d between 1 January 2005 and 31 December 2014. PDA management and in-hospital outcomes were examined for trends and variation.Results:PDA was diagnosed in 5,719 (42%) VLBW infants. Cyclooxygenase inhibitors and/or ligation were used in 74% of infants with PDA overall, however studied hospitals varied greatly in PDA management. Odds of any cyclooxygenase inhibitor or surgical treatment for PDA decreased 11% per year during the study period. This was temporally associated with improved survival but also with increasing bronchopulmonary dysplasia, periventricular leukomalacia, retinopathy of prematurity, and acute renal failure in unadjusted analyses. There was no detectable correlation between hospital-specific changes in PDA management and hospital-specific changes in outcomes of preterm birth during the study period.Conclusion:Use of cyclooxygenase inhibitors and ligation for PDA in VLBW infants decreased over a 10-y period at the studied hospitals. Further evidence is needed to assess the impact of this change in PDA management.
AB - Background:We examined recent trends and interhospital variation in use of indomethacin, ibuprofen, and surgical ligation for patent ductus arteriosus (PDA) in very-low-birth-weight (VLBW) infants.Methods:Included in this retrospective study of the Pediatric Hospital Information System database were 13,853 VLBW infants from 19 US children's hospitals, admitted at age < 3 d between 1 January 2005 and 31 December 2014. PDA management and in-hospital outcomes were examined for trends and variation.Results:PDA was diagnosed in 5,719 (42%) VLBW infants. Cyclooxygenase inhibitors and/or ligation were used in 74% of infants with PDA overall, however studied hospitals varied greatly in PDA management. Odds of any cyclooxygenase inhibitor or surgical treatment for PDA decreased 11% per year during the study period. This was temporally associated with improved survival but also with increasing bronchopulmonary dysplasia, periventricular leukomalacia, retinopathy of prematurity, and acute renal failure in unadjusted analyses. There was no detectable correlation between hospital-specific changes in PDA management and hospital-specific changes in outcomes of preterm birth during the study period.Conclusion:Use of cyclooxygenase inhibitors and ligation for PDA in VLBW infants decreased over a 10-y period at the studied hospitals. Further evidence is needed to assess the impact of this change in PDA management.
UR - http://www.scopus.com/inward/record.url?scp=84995600613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995600613&partnerID=8YFLogxK
U2 - 10.1038/pr.2016.166
DO - 10.1038/pr.2016.166
M3 - Article
C2 - 27509008
AN - SCOPUS:84995600613
SN - 0031-3998
VL - 80
SP - 785
EP - 792
JO - Pediatric Research
JF - Pediatric Research
IS - 6
ER -